Dr. WANG Qin

Post-doctoral Fellow

PhD

Field of Research

Adipose tissue biology, Adipose-mediated inter-organ crosstalk and Bone homeostasis

Biography

Dr. Wang Qin is currently a Post-doctoral Fellow at the Department of Medicine, School of Clinical Medicine, The University of Hong Kong. She received her PhD from the Department of Medicine at The University of Hong Kong in 2025. Her research focuses on elucidating the molecular mechanisms underlying obesity and its associated metabolic disorders, with particular emphasis on adipose tissue biology and adipose-mediated inter-organ crosstalk. Her work encompasses the metabolic remodeling of adipose tissue as well as its interactions with the skeletal and nervous systems, uncovering novel regulatory mechanisms and identifying potential therapeutic targets for obesity-related metabolic diseases.

Publications

Wang B, Jiang X, Wang Q, Xu A. The Multiscale Heterogeneity of Adipose Tissue in Health and Disease. Research (Wash D C). 2026 Apr 22;9:1261.
Wang B, Liu J, Wang Q, Arhatte M, Cheong LY, Glogowska E, Jiang X, Chung SK, Jin L, Hu Q, Wang Y, Honoré E, Xu A. Piezo1 activation suppresses bone marrow adipogenesis to prevent osteoporosis by inhibiting a mechanoinflammatory autocrine loop. Signal Transduct Target Ther. 2025 Oct 28;10(1):357.
Cheong LY, Wang B, Wang Q, Jin L, Kwok KHM, Wu X, Shu L, Lin H, Chung SK, Cheng KKY, Hoo RLC, Xu A. Fibroblastic reticular cells in lymph node potentiate white adipose tissue beiging through neuro-immune crosstalk in male mice. Nat Commun. 2023 Mar 3;14(1):1213.
Jin L, Geng L, Ying L, Shu L, Ye K, Yang R, Liu Y, Wang Y, Cai Y, Jiang X, Wang Q, Yan X, Liao B, Liu J, Duan F, Sweeney G, Woo CWH, Wang Y, Xia Z, Lian Q, Xu A. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity. Circulation. 2022 Nov 15;146(20):1537-1557.
Chen K, Cheong LY, Gao Y, Zhang Y, Feng T, Wang Q, Jin L, Honoré E, Lam KSL, Wang W, Hui X, Xu A. Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nat Commun. 2022 Dec 20;13(1):7838.